A Cross‐Talk Between Stromal Cell‐Derived Factor‐1 and Transforming Growth Factor‐β Controls the Quiescence/Cycling Switch of CD34+ Progenitors Through FoxO3 and Mammalian Target of Rapamycin
Abstract
Cell cycle regulation plays a fundamental role in stem cell biology. A balance between quiescence and proliferation of hematopoietic stem cells in interaction with the microenvironment is critical for sustaining long‐term hematopoiesis and for protection against stress. We analyzed the molecular mechanisms by which stromal cell‐derived factor‐1 (SDF‐1) exhibited a cell cycle‐promoting effect and interacted with transforming growth factor‐β (TGF‐β), which has negative effects on cell cycle orchestration of human hematopoietic CD34+ progenitor cells. We demonstrated that a low concentration of SDF‐1 modulated the expression of key cell cycle regulators such as cyclins, cyclin‐dependent kinase inhibitors, and TGF‐β target genes, confirming its cell cycle‐promoting effect. We showed that a cross‐talk between SDF‐1‐ and TGF‐β‐related signaling pathways involving phosphatidylinositol 3‐kinase (PI3K)/Akt phosphorylation participated in the control of CD34+ cell cycling. We demonstrated a pivotal role of two downstream effectors of the PI3K/Akt pathway, FoxO3a and mammalian target of rapamycin, as connectors in the SDF‐1‐/TGF‐β‐induced control of the cycling/quiescence switch and proposed a model integrating a dialogue between the two molecules in cell cycle progression. Our data shed new light on the signaling pathways involved in SDF‐1 cell cycle‐promoting activity and suggest that the balance between SDF‐1‐ and TGF‐β‐activated pathways is critical for the regulation of hematopoietic progenitor cell cycle status.
Disclosure of potential conflicts of interest is found at the end of this article.
Number of times cited: 30
- Claudia D. Andl, Grégoire F. Le Bras, Holli Loomans, Annette S. Kim, Linli Zhou, Yuhang Zhang and Thomas Andl, Association of TGFβ signaling with the maintenance of a quiescent stem cell niche in human oral mucosa, Histochemistry and Cell Biology, 10.1007/s00418-016-1473-0, 146, 5, (539-555), (2016).
- Silke Mühlstedt, Santhosh K. Ghadge, Johan Duchene, Fatimunnisa Qadri, Anne Järve, Larisa Vilianovich, Elena Popova, Andreas Pohlmann, Thoralf Niendorf, Philipp Boyé, Cemil Özcelik and Michael Bader, Cardiomyocyte-derived CXCL12 is not involved in cardiogenesis but plays a crucial role in myocardial infarction, Journal of Molecular Medicine, 94, 9, (1005), (2016).
- Dominik Rath, Madhumita Chatterjee, Annabell Holtkamp, Nina Tekath, Oliver Borst, Sebastian Vogel, Karin Müller, Meinrad Gawaz and Tobias Geisler, Evidence of an interaction between TGF-β1 and the SDF-1/CXCR4/CXCR7 axis in human platelets, Thrombosis Research, 144, (79), (2016).
- Ilaria Ceglia, Amylou C. Dueck, Francesca Masiello, Fabrizio Martelli, Wu He, Giulia Federici, Emanuel F. Petricoin, Ann Zeuner, Camelia Iancu-Rubin, Rona Weinberg, Ronald Hoffman, John Mascarenhas and Anna Rita Migliaccio, Preclinical rationale for TGF-β inhibition as a therapeutic target for the treatment of myelofibrosis, Experimental Hematology, 44, 12, (1138), (2016).
- Sha Hao, Chen Chen and Tao Cheng, Cell cycle regulation of hematopoietic stem or progenitor cells, International Journal of Hematology, 10.1007/s12185-016-1984-4, 103, 5, (487-497), (2016).
- Manja Wobus, Catrin List, Tobias Dittrich, Abhishek Dhawan, Regina Duryagina, Laleh S. Arabanian, Karin Kast, Pauline Wimberger, Maik Stiehler, Lorenz C. Hofbauer, Franz Jakob, Gerhard Ehninger, Konstantinos Anastassiadis and Martin Bornhäuser, Breast carcinoma cells modulate the chemoattractive activity of human bone marrow‐derived mesenchymal stromal cells by interfering with CXCL12, International Journal of Cancer, 136, 1, (44-54), (2014).
- Anuradha Vaidya and Vaijayanti P. Kale, TGF-β signaling and its role in the regulation of hematopoietic stem cells, Systems and Synthetic Biology, 9, 1-2, (1), (2015).
- Thomas Hieronymus, Martin Zenke, Jea-Hyun Baek and Kristin Seré, The clash of Langerhans cell homeostasis in skin: Should I stay or should I go?, Seminars in Cell & Developmental Biology, 41, (30), (2015).
- U. Blank and S. Karlsson, TGF- signaling in the control of hematopoietic stem cells, Blood, 125, 23, (3542), (2015).
- Muti ur Rehman Khan, Ijaz Ali, Wei Jiao, Yun Wang, Saima Masood, Muhammad Zubair Yousaf, Aqeel Javaid, Shafique Ahmad and Meifu Feng, Ex Vivo Expansion of Functional Human UCB-HSCs/HPCs by Coculture with AFT024-hkirreCells, BioMed Research International, 2014, (1), (2014).
- Audrey N. Jajosky, James E. Coad, Jeffrey A. Vos, Karen H. Martin, Jamie R. Senft, Sharon L. Wenger and Laura F. Gibson, RepSox Slows Decay of CD34+ Acute Myeloid Leukemia Cells and Decreases T Cell Immunoglobulin Mucin‐3 Expression, STEM CELLS Translational Medicine, 3, 7, (836-848), (2014).
- F. Torossian, A. Anginot, A. Chabanon, D. Clay, B. Guerton, C. Desterke, L. Boutin, S. Marullo, M. G. H. Scott, J.-J. Lataillade and M.-C. Le Bousse-Kerdiles, CXCR7 participates in CXCL12-induced CD34+ cell cycling through -arrestin-dependent Akt activation, Blood, 123, 2, (191), (2014).
- Thomas Andl, Grégoire F. Le Bras, Nicole F. Richards, Gillian L. Allison, Holli A. Loomans, M.Kay Washington, Frank Revetta, Rebecca K. Lee, Chase Taylor, Harold L. Moses and Claudia D. Andl, Concerted loss of TGFβ-mediated proliferation control and E-cadherin disrupts epithelial homeostasis and causes oral squamous cell carcinoma, Carcinogenesis, 10.1093/carcin/bgu194, 35, 11, (2602-2610), (2014).
- Maria-Christina Kastrinaki, Konstantia Pavlaki, Aristea K. Batsali, Elisavet Kouvidi, Irene Mavroudi, Charalampos Pontikoglou and Helen A. Papadaki, Mesenchymal Stem Cells in Immune-Mediated Bone Marrow Failure Syndromes, Clinical and Developmental Immunology, 2013, (1), (2013).
- J-S Delisle, M Giroux, G Boucher, J-R Landry, M-P Hardy, S Lemieux, R G Jones, B T Wilhelm and C Perreault, The TGF-β-Smad3 pathway inhibits CD28-dependent cell growth and proliferation of CD4 T cells, Genes & Immunity, 14, 2, (115), (2013).
- Sébastien Albert, Maria Eugenia Riveiro, Caroline Halimi, Muriel Hourseau, Anne Couvelard, Maria Serova, Béatrix Barry, Eric Raymond, Sandrine Faivre and Jeffrey N. Myers, Focus on the role of the CXCL12/CXCR4 chemokine axis in head and neck squamous cell carcinoma, Head & Neck, 35, 12, (1819-1828), (2013).
- Stephanie L. Rellick, Heather O'Leary, Debbie Piktel, Cheryl Walton, James E. Fortney, Stephen M. Akers, Karen H. Martin, James Denvir, Goran Boskovic, Donald A. Primerano, Jeffrey Vos, Nathanael Bailey, Marieta Gencheva, Laura F. Gibson and Marc Tjwa, Bone Marrow Osteoblast Damage by Chemotherapeutic Agents, PLoS ONE, 7, 2, (e30758), (2012).
- Eugenia Flores-Figueroa, Sushama Varma, Kelli Montgomery, Peter L Greenberg and Dita Gratzinger, Distinctive contact between CD34+ hematopoietic progenitors and CXCL12+ CD271+ mesenchymal stromal cells in benign and myelodysplastic bone marrow, Laboratory Investigation, 92, 9, (1330), (2012).
- Chenchen Zhou, Jeffrey Liu, Yaling Tang and Xinhua Liang, Inflammation linking EMT and cancer stem cells, Oral Oncology, 10.1016/j.oraloncology.2012.06.005, 48, 11, (1068-1075), (2012).
- Simone G Fonseca, Francesco A Procopio, Jean-Philippe Goulet, Bader Yassine-Diab, Petronela Ancuta and Rafick-Pierre Sékaly, Unique features of memory T cells in HIV elite controllers: a systems biology perspective, Current Opinion in HIV and AIDS, 10.1097/COH.0b013e32834589a1, 6, 3, (188-196), (2011).
- Rita Campanelli, Vittorio Rosti, Laura Villani, Marta Castagno, Enza Moretti, Elisa Bonetti, Gaetano Bergamaschi, Alessandra Balduini, Giovanni Barosi and Margherita Massa, Evaluation of the bioactive and total transforming growth factor β1 levels in primary myelofibrosis, Cytokine, 53, 1, (100), (2011).
- Menka Sharma, Farhat Afrin, Neeraj Satija, Rajendra P. Tripathi and Gurudutta U. Gangenahalli, Stromal-Derived Factor-1/ CXCR4 Signaling: Indispensable Role in Homing and Engraftment of Hematopoietic Stem Cells in Bone Marrow , Stem Cells and Development, 10.1089/scd.2010.0263, 20, 6, (933-946), (2011).
- Mahesh Kandasamy, Ralf Reilmann, Jürgen Winkler, Ulrich Bogdahn and Ludwig Aigner, Transforming Growth Factor-Beta Signaling in the Neural Stem Cell Niche: A Therapeutic Target for Huntington's Disease, Neurology Research International, 2011, (1), (2011).
- Asumi Yokota, Shinya Kimura, Ruriko Tanaka, Miki Takeuchi, Hisayuki Yao, Kazuki Sakai, Rina Nagao, Junya Kuroda, Yuri Kamitsuji, Eri Kawata, Eishi Ashihara and Taira Maekawa, Osteoclasts are involved in the maintenance of dormant leukemic cells, Leukemia Research, 34, 6, (793), (2010).
- Marijke W. Maijenburg, Willy A. Noort, Marion Kleijer, Charlotte J. A. Kompier, Kees Weijer, Jaap D. van Buul, C. Ellen van der Schoot and Carlijn Voermans, Cell cycle and tissue of origin contribute to the migratory behaviour of human fetal and adult mesenchymal stromal cells, British Journal of Haematology, 148, 3, (428), (2010).
- Mahesh Kandasamy, Sebastien Couillard-Despres, Kerstin A. Raber, Michael Stephan, Bernadette Lehner, Beate Winner, Zacharias Kohl, Francisco J. Rivera, Huu Phuc Nguyen, Olaf Riess, Ulrich Bogdahn, Jürgen Winkler, Stephan von Hörsten and Ludwig Aigner, Stem Cell Quiescence in the Hippocampal Neurogenic Niche Is Associated With Elevated Transforming Growth Factor-β Signaling in an Animal Model of Huntington Disease, Journal of Neuropathology & Experimental Neurology, 69, 7, (717), (2010).
- Grant A. Challen, Nathan C. Boles, Stuart M. Chambers and Margaret A. Goodell, Distinct Hematopoietic Stem Cell Subtypes Are Differentially Regulated by TGF-β1, Cell Stem Cell, 6, 3, (265), (2010).
- Alberto M. Martelli, Camilla Evangelisti, Francesca Chiarini, Cecilia Grimaldi, Alessandra Cappellini, Andrea Ognibene and James A. McCubrey, The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1803, 9, (991), (2010).
- Andre Tanel, Simone G Fonseca, Bader Yassine-Diab, Rebeka Bordi, Joumana Zeidan, Yu Shi, Clarisse Benne and Rafick-Pierre Sékaly, Cellular and molecular mechanisms of memory T-cell survival, Expert Review of Vaccines, 8, 3, (299), (2009).
- Lisa Pleyer, Peter Valent and Richard Greil, Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis—Masters of Survival and Clonality?, International Journal of Molecular Sciences, 10.3390/ijms17071009, 17, 7, (1009), (2016).




